Internal Medicine, Pulmonary Disease · Boston, MA
NPI
1083774673
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
55 Fruit St, Blake 7
Boston, MA, 02114
Phone (617) 726-1721
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
547 services
Medicare patients, 2024
90
Average age 62
Drug cost, 2024
$4.4M
486 prescriptions
Company payments, 2025
$287
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Isabel P Neuringer was code 99233 (hospital e&m - subsequent), 295 times for 43 patients. In total Isabel P Neuringer billed 547 services in 12 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 295 | 43 | $98.32 | $29K |
| 99214 Office E&M - Established | Facility | 91 | 45 | $72.84 | $6,628 |
| 99291 Critical Care E&M | Facility | 56 | 12 | $175.55 | $9,831 |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 12 | $65.69 | $2,759 |
| 99223 Hospital E&M - Initial | Facility | 22 | 18 | $140.30 | $3,087 |
| 99215 Office E&M - Established | Facility | 20 | 18 | $118.36 | $2,367 |
By year: 2022 $50K for 561 services; 2023 $54K for 552 services; 2024 $56K for 547 services.
Medicare prescription drug claims, 2024
In 2024, the drug Isabel P Neuringer prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 111 prescriptions and refills. In total Isabel P Neuringer wrote 486 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 111 | 119 | 14 | $3.3M |
| Creon Lipase/Protease/Amylase | 40 | 42 | Under 11 | $189K |
| Zenpep Lipase/Protease/Amylase | 24 | 39 | Under 11 | $154K |
| Azithromycin Generic | 19 | 34 | Under 11 | $264 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 | 18 | Under 11 | $660 |
| Ciprofloxacin Hcl Generic | 17 | 17 | Under 11 | $136 |
| Doxycycline Monohydrate Generic | 16 | 16 | Under 11 | $194 |
| Prednisone Generic | 14 | 18 | Under 11 | $90.06 |
| Kalydeco Ivacaftor | 13 | 13 | Under 11 | $392K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 13 | 13 | Under 11 | $283 |
| Omeprazole Generic | 11 | 28 | Under 11 | $301 |
Brand drugs: 256 claims; generic drugs: 230 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Isabel P Neuringer $287 ($287 in general payments such as food, travel and fees) from 2 companies. The largest payer was Viatris Specialty LLC with $221.
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 1 | $221 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $66.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.